WCG MAGI Clinical Research Hybrid Conference –2022 East

A Meeting That Matters

The MAGI Clinical Research hybrid conference offers sponsors the most powerful and efficient platform for establishing brand credibility, identifying high-quality sales prospects and communicating directly with those prospects to move them decisively down the sales funnel to actual purchases.

How important would it be to present your company’s value proposition to more than a thousand highly qualified clinical research executives, buyers and end-users who will attend the MAGI Clinical Research Hybrid Conference in 2022? Or for your sales staff to be able to reach attendees directly through in-person connections, chats, emails and texts? Very important, based on results from the two highly attended MAGI conferences held in 2021.

Laser Focus on Visibility and Engagement

Sponsors of MAGI’s Clinical Research hybrid conference will find an exciting range of innovative options for a) achieving high visibility for their brand and top executives, b) identifying large numbers of precisely qualified prospects for their company’s products and services and c) initiating genuine, personal engagement with prospects that can effectively lead to sales. No other event provides such a smooth, efficient connection between your sales team and large numbers of buyers.

Demographics

MAGI’s clinical research conferences give event sponsors access to more qualified decisionmakers, buyers and end-users. A record 1,100 high-level attendees participated in our last event, with more than half having direct buying authority, including 100+ C-suite executives and 500+ executives described as directors or senior level. Study sponsors will be split about 75% biopharma and 25% medical device. Sites will be almost evenly divided among a) academic medical centers, b) health systems and community hospitals and c) independent sites and clinics.